How Much Did Sharps Technology Raise?
Funding & Key Investors

Sharps Technology, a medical device innovator, has secured substantial enterprise-level funding, with its total capital raised standing at $814.4M. The company recently announced a major strategic investment of $410.9M, underscoring its pivotal role in advancing healthcare safety. This latest financing round is expected to accelerate the development and deployment of its groundbreaking safety syringe technology.

What is Sharps Technology?

Sharps Technology
ManufacturingMedical Devices & Equipment

Sharps Technology is a medical device company headquartered in Melville, New York, dedicated to mitigating the risks associated with needlestick injuries. The company's core innovation lies in its smart safety syringes, engineered to prevent approximately two million potentially infectious accidental needlestick injuries annually. This focus positions Sharps Technology at the forefront of patient and healthcare worker safety within the global medical device market. The company's commitment to addressing a critical healthcare challenge is reflected in its ongoing pursuit of significant capital to scale its operations and market reach.

How much funding has Sharps Technology raised?

Sharps Technology has raised a total of $814.4M across 3 funding rounds:

2024

Share Placement

$3.5M

2025

Stock/Share Issuance

$400M

Private Equity

$410.9M

Share Placement (2024): $3.5M with participation from Aegis Capital Corp

Stock/Share Issuance (2025): $400M, investors not publicly disclosed

Private Equity (2025): $410.9M, investors not publicly disclosed

Key Investors in Sharps Technology

Aegis Capital Corp

Aegis Capital Corporation is an established financial services firm with over 35 years of experience, offering a comprehensive suite of investment banking and wealth management services to a diverse clientele.

What's next for Sharps Technology?

With the infusion of $410.9M in a major strategic investment and a cumulative total of $814.4M, Sharps Technology is poised for significant expansion. This substantial backing, particularly in the context of enterprise-level funding, suggests a strategic phase focused on scaling manufacturing, broadening market penetration, and potentially exploring new product lines or geographical markets. The company's trajectory indicates a strong emphasis on solidifying its market position and capitalizing on the growing demand for advanced safety medical devices. Future developments will likely center on the successful integration of this new capital to drive operational efficiencies and enhance its competitive advantage in the medical technology sector.

See full Sharps Technology company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

Aerospace & DefenseManufacturing
Boats & SubmarinesManufacturingMarine Shipping & TransportationTransportation
Building MaterialsManufacturingHome Improvement & Hardware RetailRetail
Health & Nutrition ProductsManufacturingRetailVitamins, Supplements & Health Stores

Frequently Asked Questions Regarding Sharps Technology Financial Insights

What are the most recent funding rounds that Sharps Technology has completed, and what were the funding rounds?
Sharps Technology has recently completed 3 funding rounds: Private Equity on Oct 31, 2025, Stock/Share Issuance on Aug 26, 2025, Share Placement on Nov 4, 2024.
What is the total amount of funding Sharps Technology has raised to date?
Sharps Technology has raised a total of $814.4M in funding to date.
How many funding rounds has Sharps Technology completed?
Sharps Technology has completed 3 funding rounds.
How much funding did Sharps Technology raise in its most recent funding round?
Sharps Technology raised $410.9M in its most recent funding round.
Which was the largest funding round in Sharps Technology's history?
The largest funding round in Sharps Technology's history was $410.9M.
See more information about Sharps Technology